Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3123 results found
Expand All
Apply All
3123 results found

BIO IMPACT: Calculating the Benefits of Biotechnology
Share
Webinars  •  October 5, 2021
Calculating the Benefits of Biotechnology Climate change is a clear and present danger to society. Industries and governments are taking action to confront this crisis, committing to sustainability goals that reduce environmental impact and improve the health and well-being of communities. To be confident in sustainability claims, it is critical to accurately calculate the environmental benefits of biotechnologies and how that value transfers through complex supply chains. Our BIO Impact webinar will explore efforts to promote consistent sustainability accounting, as well as highlight BIO members’ transformative innovations and the partnerships & collaborations that are leveraging the demands of climate mitigation and propelling a resilient biobased economy of the future.
Read More
Benefits of Biotechnology

Good Day BIO: This could be the first oral COVID therapeutic
Share
Good Day BIO Newsletter  •  October 4, 2021
Starting the week with good news: Merck and Ridgeback plan to seek the authorization of what would be the first oral COVID-19 therapeutic, which could change the game when it comes to treating unavoidable infection. We also look at how gene editing could rescue our food supply from climate challenges. (756 words, 3 minutes, 46 seconds)Real quick: Don't forget to register for tomorrow's BIO IMPACT Webinar on Calculating the Benefits of Biotechnology.
Read More

Good Day BIO: Why we need to protect Qualified Small Business Stock
Share
Good Day BIO Newsletter  •  October 1, 2021
A new month—and the government’s not shut down. But there are still a few things we’re worried about, including proposed changes to Qualified Small Business Stock and proposed Prescription Drug Pricing Boards in several states. We explain why these are bad ideas. (782 words, 3 minutes, 54 seconds)
Read More

BIO Supporting Oxitec’s Experimental Use Permit (EUP) for Biotech Mosquito
Share
Agriculture & Environment, Food & Farm Innovation  •  Letters, Testimony & Comments  •  September 30, 2021
The Biotechnology Innovation Organization (BIO) submits these comments in response to the U.S. Environmental Protection Agency’s (EPA) request for public input on the receipt of an application, 93167-EUP-2, from Oxitec Ltd requesting to amend and extend of an experimental use permit (EUP) for the OX5034 Aedes aegypti mosquitoes expressing tetracycline Trans-Activator Variant protein. The mosquitoes are proposed to be released in Florida and California to evaluate the efficacy of the mosquitoes as a tool for suppression of wild Aedes aegypti mosquito populations. The release would be an amendment and extension of an EUP authorized in April 2020.
Read More

BIO Signs Letter to House Leadership on Need to Protect Qualified Small Business Stock
Share
Letters, Testimony & Comments  •  September 30, 2021
The undersigned organizations write to encourage policymakers to remove provisions in the Build Back Better Act that would curtail the effectiveness of Qualified Small Business Stock (QSBS) in incentivizing investment in innovative small businesses and startups.
Read More

Good Day BIO: USDA's new climate initiative – plus, Rare Cancer Day insights
Share
Good Day BIO Newsletter  •  September 30, 2021
Expect a crazy day in D.C. as Congress prepares to vote on government funding and, maybe, infrastructure. Meanwhile, USDA announced a new climate-smart ag and forestry initiative. And, it’s Rare Cancer Day—here’s how we can help or hinder promising treatments. (904 words, 4 minutes, 31 seconds)
Read More

Good Day BIO: Sickle Cell Awareness Month and food news
Share
Good Day BIO Newsletter  •  September 29, 2021
For Sickle Cell Awareness Month, we spoke to one patient advocate about her experience with the disease—and we explain why proposed drug price controls could make disparities in research even worse. We also have a lot of news on gene editing for food from around the world, and why it matters. (941 words, 4 minutes, 42 seconds)
Read More

112 Enablement: What to Watch Out For – Enablement & Functional Claiming
Share
Webinars  •  September 29, 2021
Join the Biotechnology Innovation Organization (BIO) for an expert discussion on Section 112, focusing on the enablement of functional language. We'll review how this is playing out in district court litigation and in the PTAB and also discuss potential prosecution strategies. The discussion will focus on recent enablement-related cases, including Amgen v. Sanofi and the cases that led to that landmark decision.  
Read More

Save Cures
Share

Good Day BIO: How price controls hurt patients
Share
Good Day BIO Newsletter  •  September 28, 2021
The government’s not the only thing that might shut down. Proposed drug price controls could shut down investment in future cures and harm patients—today’s new episode of the I am BIO Podcast explains why. Plus, BIO IMPACT 2021 begins in one week—we have details about how BIO and our members are tackling climate. (811 words, 4 minutes, 3 seconds)
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 167
  • 168
  • 169
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO